1. Academic Validation
  2. Whole proteome analysis of human tankyrase knockout cells reveals targets of tankyrase-mediated degradation

Whole proteome analysis of human tankyrase knockout cells reveals targets of tankyrase-mediated degradation

  • Nat Commun. 2017 Dec 20;8(1):2214. doi: 10.1038/s41467-017-02363-w.
Amit Bhardwaj 1 Yanling Yang 2 Beatrix Ueberheide 2 Susan Smith 3
Affiliations

Affiliations

  • 1 Kimmel Center for Biology and Medicine at the Skirball Institute, Department of Pathology, New York University School of Medicine, New York, NY, 10016, USA.
  • 2 Proteomics Laboratory, Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY, 10016, USA.
  • 3 Kimmel Center for Biology and Medicine at the Skirball Institute, Department of Pathology, New York University School of Medicine, New York, NY, 10016, USA. [email protected].
Abstract

Tankyrase 1 and 2 are poly(ADP-ribose) polymerases that function in pathways critical to Cancer cell growth. Tankyrase-mediated PARylation marks protein targets for proteasomal degradation. Here, we generate human knockout cell lines to examine cell function and interrogate the proteome. We show that either tankyrase 1 or 2 is sufficient to maintain telomere length, but both are required to resolve telomere cohesion and maintain mitotic spindle integrity. Quantitative analysis of the proteome of tankyrase double knockout cells using isobaric tandem mass tags reveals targets of degradation, including antagonists of the Wnt/β-catenin signaling pathway (NKD1, NKD2, and HectD1) and three (Notch 1, 2, and 3) of the four Notch receptors. We show that tankyrases are required for Notch2 to exit the plasma membrane and enter the nucleus to activate transcription. Considering that Notch signaling is commonly activated in Cancer, tankyrase inhibitors may have therapeutic potential in targeting this pathway.

Figures